What is the ICL Bronchial Provocation Test?
The term "ICL" does not appear to be a standard or recognized abbreviation for any established bronchial provocation test in the medical literature or current guidelines. Based on the available evidence, there is no validated test called an "ICL bronchial provocation test" in respiratory medicine.
Standard Bronchial Provocation Tests
Bronchial provocation (challenge) tests are diagnostic procedures used to assess airway hyperresponsiveness, primarily in the evaluation of asthma. These tests fall into two main categories 1:
Direct Challenge Tests
Direct challenges act directly on airway smooth muscle receptors and include:
- Methacholine challenge - the most commonly used direct test
- Histamine challenge
These tests cause airflow limitation predominantly through direct smooth muscle contraction and are highly sensitive for detecting airway hyperresponsiveness, though less specific for asthma 2, 3.
Indirect Challenge Tests
Indirect challenges trigger airway narrowing by activating inflammatory cells, epithelial cells, and nerves that release mediators causing smooth muscle contraction 1. These include:
- Exercise challenge
- Eucapnic voluntary hyperpnoea (EVH)
- Hypertonic saline challenge
- Mannitol challenge
- Adenosine monophosphate (AMP) challenge 1
Indirect challenges are more specific for asthma but less sensitive than direct tests 4.
Common Pitfalls
If you encountered "ICL" in a clinical context, consider these possibilities:
- Misinterpretation or abbreviation error - It may refer to a specific institutional protocol
- Confusion with established tests - Could be referring to inhalation challenge tests generally
- Regional or non-standard terminology - Some facilities use local abbreviations
For clinical practice, use standardized bronchial challenge tests with established protocols 5, 6. The methacholine challenge remains the gold standard direct test, while exercise or mannitol challenges are preferred indirect tests depending on clinical indication 4.